423 related articles for article (PubMed ID: 18986735)
1. The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting.
Marra AR; de Almeida SM; Correa L; Silva M; Martino MD; Silva CV; Cal RG; Edmond MB; dos Santos OF
Am J Infect Control; 2009 Apr; 37(3):204-9. PubMed ID: 18986735
[TBL] [Abstract][Full Text] [Related]
2. Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit.
Jacoby TS; Kuchenbecker RS; Dos Santos RP; Magedanz L; Guzatto P; Moreira LB
J Hosp Infect; 2010 May; 75(1):23-7. PubMed ID: 20338669
[TBL] [Abstract][Full Text] [Related]
3. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram.
Cook PP; Catrou PG; Christie JD; Young PD; Polk RE
J Antimicrob Chemother; 2004 May; 53(5):853-9. PubMed ID: 15044426
[TBL] [Abstract][Full Text] [Related]
4. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study.
Apisarnthanarak A; Pinitchai U; Thongphubeth K; Yuekyen C; Warren DK; Fraser VJ;
Clin Infect Dis; 2008 Sep; 47(6):760-7. PubMed ID: 18684100
[TBL] [Abstract][Full Text] [Related]
5. Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced.
Meyer E; Buttler J; Schneider C; Strehl E; Schroeren-Boersch B; Gastmeier P; Ruden H; Zentner J; Daschner FD; Schwab F
J Antimicrob Chemother; 2007 Jun; 59(6):1148-54. PubMed ID: 17434880
[TBL] [Abstract][Full Text] [Related]
6. [Impact of antibiotic use and prescribing policy in a Tunisian intensive care unit].
Brahmi N; Blel Y; Kouraichi N; Ben Hamouda R; Thabet H; Amamou M
Med Mal Infect; 2006 Sep; 36(9):460-5. PubMed ID: 17027213
[TBL] [Abstract][Full Text] [Related]
7. [Implementation of antimicrobial resistance surveillance and antibiotic consumption in an intensive care burn department].
Messadi AA; Thabet L; Bousselmi K; Oueslati S; Ben Redjeb S
Tunis Med; 2008 May; 86(5):486-9. PubMed ID: 19469305
[TBL] [Abstract][Full Text] [Related]
8. The clinical consequences of antimicrobial resistance.
Rice LB
Curr Opin Microbiol; 2009 Oct; 12(5):476-81. PubMed ID: 19716760
[TBL] [Abstract][Full Text] [Related]
9. [Evolution of antibiotic consumption in an intensive care burn department].
Thabet L; Bousselmi K; Oueslati S; Memmi M; Ben Redjeb S; Messadi AA
Tunis Med; 2007 Dec; 85(12):1035-8. PubMed ID: 19170383
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence and in vitro antimicrobial susceptibility patterns of Acinetobacter baumannii strains in a Moroccan university hospital].
Lahsoune M; Boutayeb H; Zerouali K; Belabbes H; El Mdaghri N
Med Mal Infect; 2007 Dec; 37(12):828-31. PubMed ID: 17669611
[TBL] [Abstract][Full Text] [Related]
11. Impact of diversity of antibiotic use on the development of antimicrobial resistance.
Sandiumenge A; Diaz E; Rodriguez A; Vidaur L; Canadell L; Olona M; Rue M; Rello J
J Antimicrob Chemother; 2006 Jun; 57(6):1197-204. PubMed ID: 16565158
[TBL] [Abstract][Full Text] [Related]
12. Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance.
Arda B; Sipahi OR; Yamazhan T; Tasbakan M; Pullukcu H; Tunger A; Buke C; Ulusoy S
J Infect; 2007 Jul; 55(1):41-8. PubMed ID: 17512598
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.
Jang TN; Lee SH; Huang CH; Lee CL; Chen WY
J Hosp Infect; 2009 Oct; 73(2):143-50. PubMed ID: 19716203
[TBL] [Abstract][Full Text] [Related]
14. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
[TBL] [Abstract][Full Text] [Related]
15. Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units).
Meyer E; Schwab F; Gastmeier P; Rueden H; Daschner FD; Jonas D
J Hosp Infect; 2006 Nov; 64(3):238-43. PubMed ID: 16979794
[TBL] [Abstract][Full Text] [Related]
16. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
Jamulitrat S; Arunpan P; Phainuphong P
J Med Assoc Thai; 2009 Mar; 92(3):413-9. PubMed ID: 19301737
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand.
Apisarnthanarak A; Danchaivijitr S; Khawcharoenporn T; Limsrivilai J; Warachan B; Bailey TC; Fraser VJ;
Clin Infect Dis; 2006 Mar; 42(6):768-75. PubMed ID: 16477551
[TBL] [Abstract][Full Text] [Related]
18. [Use of systemic antibacterial agents at a university emergency clinic in Bucharest, in the year 2008].
Ion-Nedelcu N; Radu L; Firulescu S; Truţă E; Sîrbu M; Barbu G; Calistru P
Bacteriol Virusol Parazitol Epidemiol; 2009; 54(1):53-8. PubMed ID: 20524396
[TBL] [Abstract][Full Text] [Related]
19. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit.
Raineri E; Pan A; Mondello P; Acquarolo A; Candiani A; Crema L
Am J Infect Control; 2008 May; 36(4):283-90. PubMed ID: 18455049
[TBL] [Abstract][Full Text] [Related]
20. Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections.
Allegranzi B; Luzzati R; Luzzani A; Girardini F; Antozzi L; Raiteri R; Di Perri G; Concia E
J Hosp Infect; 2002 Oct; 52(2):136-40. PubMed ID: 12392905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
